PacBio (PACB) Q4 Earnings Beat, Adjusted Gross Margin Down

Pacific Biosciences of California, Inc. (PACB) , popularly known as PacBio, delivered an adjusted loss per share of 27 cents in fourth-quarter 2023, narrower than the year-ago loss of 35 cents per share. The adjusted loss per share was also narrower than the Zacks Consensus Estimate of a loss of 31 cents.The company’s GAAP loss per share was 31 cents in the quarter, narrower than the year-ago period’s loss of 37 cents.Full-year adjusted loss per share was $1.11, narrower than the loss of $1.38 per share at ...